Lymphocytic Esophagitis: Assessing Risk Factors and Clinical Outcomes.
Himesh B ZaverHassan GhozBalkishan J MalviyaBhaumik BrahmbhattWilliam C PalmerBrian E LacyKenneth R DeVaultMurli KrishnaYan BiPublished in: Digestive diseases and sciences (2020)
Our data suggests that lymphocytic esophagitis is more likely to be found in older female patients and is significantly associated with achalasia, statin, and aspirin use. Compared to eosinophilic esophagitis, lymphocytic esophagitis is more likely to respond to treatment with medical therapy.
Keyphrases
- risk factors
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- low dose
- cardiovascular disease
- coronary artery disease
- physical activity
- stem cells
- cardiovascular events
- machine learning
- antiplatelet therapy
- acute coronary syndrome
- deep learning
- atrial fibrillation
- bone marrow
- artificial intelligence
- cell therapy
- data analysis